Whilst the latest European Commission 2018 economic growth forecast for the EU stands at 2.3%, a large group of Eastern European countries clearly outpaces its European peers. Slovenia, Romania and Bulgaria lead the pack as shown on the chart below. Growth in the above CEE countries is forecast to
SOFIA (Bulgaria), June 22 (SeeNews) – Bulgarian drug distributor and retailer Sopharma Trading [BUL:SO5] plans to expand its operations on the Serbian market and to become a strategic investor in Southeast Europe (SEE), it said. Sopharma Trading is planning to implement its successful diversified
Azerbaijan’s Sumgait city has hosted the groundbreaking ceremony of the first plant for the production of solid drugs. The ceremony was attended by Azerbaijan’s Economy Minister Shahin Mustafayev. During the event, it was noted that products of the plant, which is being built by India’s Sun
Although Poland has a very strong scientific base in life sciences and medicine, it has not developed a vibrant biotech or medtech sectors. Until recently, no truly innovative products from Poland have been introduced to the global market. The pharmaceutical industry has traditionally been based on
The Czech Health Ministry prepared draft amendments to the Public Health Insurance Act, which will introduce new reimbursement rules for medical devices, the Ministry said. The new rules are expected to come into force in January 2019, replacing current regulations that were contested by the
Medicines in Kazakhstan rose by 7% in 2018 Q1, Energyprom.kz reports. According to 2018 first quarter results, prices for pharmaceutical products rose 2% compared to the previous quarter and by 6.6% on-year. The most noticeable annual price rise was recorded in the hormonal drugs segment – by
The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market. Following Part 7 Article 14 of the Law on Pharmacy in the
In February 2018, the Bulgarian Drug Agency (BDA) announced new requirements for fee payments which are important for all applicants, marketing authorisation holders and their representatives. When requesting an administrative service for marketing authorization/registration, variations, renewals
NEWS REGULATORY CONSULTING PHARMACOVIGILANCE SERVICES MARKET ACCESS SERVICES MARKETING AND SALES Kazakhstan Pharmaceutical and Medical Device Market Trends In February 2018, the Bulgarian Drug Agency (BDA) announced new requirements for fee payments which are important for all applicants, marketing authorisation holders and their representatives. When requesting an administrative service for marketing authorization/registration, variations, renewals of…
The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market. We here with remind that following Part 7 Article 14 of the Law on Pharmacy in…